1,721,045 research outputs found

    P. Pensabene, M. A. Rizzo, M. Roghi, E. Talamo, Terracotte votive dal Tevere

    No full text
    Pailler Jean-Marie. P. Pensabene, M. A. Rizzo, M. Roghi, E. Talamo, Terracotte votive dal Tevere. In: Annales. Économies, Sociétés, Civilisations. 38ᵉ année, N. 4, 1983. pp. 957-958

    P. Pensabene, M. A. Rizzo, M. Roghi, E. Talamo, Terracotte votive dal Tevere

    No full text
    Pailler Jean-Marie. P. Pensabene, M. A. Rizzo, M. Roghi, E. Talamo, Terracotte votive dal Tevere. In: Annales. Économies, Sociétés, Civilisations. 38ᵉ année, N. 4, 1983. pp. 957-958

    Pietre che camminano: il colore e il prestigio dei marmi antichi nell’Ottocento roma

    No full text
    One of the peculiarities of the Papal architecture of the 19th century in Rome is the use of stones and coloured marbles, often for reuse, according to the taste and the building practice of the great Renaissance and Baroque tradition. The use of ancient, prized and sometimes rare stones attributed to the architectures a strong prestige and a symbolic charge, binding them ideally to the immortal values of Classicism and the great Christian architecture of imperial matrix. Furthermore, the retrieval, transport and processing of the stones, intended for these architectures, represented steps of a flourishing and profitable economic activity in the Papal State; steps all of which had a direct impact on the town, its economic organization and urban structure. The Confession of the Basilica of Santa Maria Maggiore in Rome, made between 1861 and 1864, represents in its architectural and chromatic syntax (geometry of the intarsia, colours and patterns of the stones, their distribution) the result of a conceptual process and of a coordinated activity of specialized workers: a world that closes its long life cycle at the dawn of the 20th Century

    Going Beyond Counting First Authors in Author Co-citation Analysis

    Full text link
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    Male Breast Cancer: From Molecular Genetics to Clinical Management

    No full text
    : MBC is a rare disease accounting for almost 1% of all cancers in men and less than 1% of breast cancer. Emerging data on the genetic drivers of predisposition for MBC are available and different risk factors have been associated with its pathogenesis. Genetic alterations, such as pathogenetic variants in BRCA1/2 and other moderate-/low-penetrance genes, along with non-genetic risk factors, have been recognized as pathogenic factors for MBC. Preventive and therapeutic implications could be related to the detection of alterations in predisposing genes, especially BRCA1/2, and to the identification of oncogenic drivers different from FBC. However, approved treatments for MBC remain the same as FBC. Cancer genetic counseling has to be considered in the diagnostic work-up of MBC with or without positive oncological family history. Here, we review the literature, reporting recent data about this malignancy with a specific focus on epidemiology, and genetic and non-genetic risk factors. We introduce the perspective of cancer genetic counseling for MBC patients and their healthy at-risk family members, with a focus on different hereditary cancer syndromes
    corecore